Samlyn Capital’s Allergan Inc AGN Stock Holding History

Samlyn Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-675,186	Closed	-$144M	–	123
2014 Q4	$144M	Sell	675,186 -408,300	-38%	-$81.2M	2.49%	3
2014 Q3	$193M	Buy	1,083,486 +153,204	+16%	+$25.4M	3.99%	1
2014 Q2	$157M	Buy	930,282 +597,509	+180%	+$93M	3.58%	1
2014 Q1	$41.3M	Buy	332,773 +61,667	+23%	+$7.51M	0.96%	47
2013 Q4	$30.1M	Sell	271,106 -68,400	-20%	-$6.53M	0.75%	53
2013 Q3	$30.7M	Buy	339,506 +101,306	+43%	+$9.09M	0.86%	50
2013 Q2	$20.1M	Buy	+238,200	New	+$24.7M	0.59%	67

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Samlyn Capital's AGN Position: Q1 2015 in Review

Samlyn Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 675,186 shares — an estimated $144M sold.

Samlyn Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $193M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Samlyn Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Samlyn Capital sold 675,186 Allergan Inc shares in Q1 2015, an estimated $144M.
Samlyn Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Samlyn Capital's Allergan Inc position peaked at $193M in Q3 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Samlyn Capital's 13F filing for Q1 2015, filed 15 May 2015.